BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30897344)

  • 61. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
    Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
    J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion.
    Bartneck M; Koppe C; Fech V; Warzecha KT; Kohlhepp M; Huss S; Weiskirchen R; Trautwein C; Luedde T; Tacke F
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):327-347. PubMed ID: 32896623
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
    Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
    J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
    Moustafa T; Fickert P; Magnes C; Guelly C; Thueringer A; Frank S; Kratky D; Sattler W; Reicher H; Sinner F; Gumhold J; Silbert D; Fauler G; Höfler G; Lass A; Zechner R; Trauner M
    Gastroenterology; 2012 Jan; 142(1):140-151.e12. PubMed ID: 22001865
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
    Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
    Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma.
    Park TJ; Kim HS; Byun KH; Jang JJ; Lee YS; Lim IK
    Mol Carcinog; 2001 Mar; 30(3):138-50. PubMed ID: 11301474
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interleukin 6-dependent genomic instability heralds accelerated carcinogenesis following liver regeneration on a background of chronic hepatitis.
    Lanton T; Shriki A; Nechemia-Arbely Y; Abramovitch R; Levkovitch O; Adar R; Rosenberg N; Paldor M; Goldenberg D; Sonnenblick A; Peled A; Rose-John S; Galun E; Axelrod JH
    Hepatology; 2017 May; 65(5):1600-1611. PubMed ID: 28027584
    [TBL] [Abstract][Full Text] [Related]  

  • 69. p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury.
    Marhenke S; Buitrago-Molina LE; Endig J; Orlik J; Schweitzer N; Klett S; Longerich T; Geffers R; Sánchez Muñoz A; Dorrell C; Katz SF; Lechel A; Weng H; Krech T; Lehmann U; Dooley S; Rudolph KL; Manns MP; Vogel A
    Gut; 2014 Sep; 63(9):1501-12. PubMed ID: 24092862
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
    Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
    Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatocytic p62 suppresses ductular reaction and tumorigenesis in mouse livers with mTORC1 activation and defective autophagy.
    Chao X; Wang S; Fulte S; Ma X; Ahamed F; Cui W; Liu Z; Rülicke T; Zatloukal K; Zong WX; Liu W; Ni HM; Ding WX
    J Hepatol; 2022 Mar; 76(3):639-651. PubMed ID: 34710483
    [TBL] [Abstract][Full Text] [Related]  

  • 72. FUN14 Domain-Containing 1-Mediated Mitophagy Suppresses Hepatocarcinogenesis by Inhibition of Inflammasome Activation in Mice.
    Li W; Li Y; Siraj S; Jin H; Fan Y; Yang X; Huang X; Wang X; Wang J; Liu L; Du L; Chen Q
    Hepatology; 2019 Feb; 69(2):604-621. PubMed ID: 30053328
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inflammatory disease and cancer with a decrease in Kupffer cell numbers in Nucling-knockout mice.
    Sakai T; Liu L; Teng X; Ishimaru N; Mukai-Sakai R; Tran NH; Kim SM; Sano N; Hayashi Y; Kaji R; Fukui K
    Int J Cancer; 2010 Mar; 126(5):1079-94. PubMed ID: 19637241
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
    Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R
    Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment.
    Liu WT; Jing YY; Gao L; Li R; Yang X; Pan XR; Yang Y; Meng Y; Hou XJ; Zhao QD; Han ZP; Wei LX
    Cell Death Differ; 2020 Jan; 27(1):85-101. PubMed ID: 31065105
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Depletion of S100A4
    Jiao J; González Á; Stevenson HL; Gagea M; Sugimoto H; Kalluri R; Beretta L
    Exp Mol Med; 2018 Jan; 50(1):e422. PubMed ID: 29303514
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
    Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
    Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice.
    Lim BJ; Lee WK; Lee HW; Lee KS; Kim JK; Chang HY; Lee JI
    Cell Commun Signal; 2018 Dec; 16(1):93. PubMed ID: 30509307
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model.
    Yasmin A; Regan DP; Schook LB; Gaba RC; Schachtschneider KM
    Biochimie; 2021 Mar; 182():73-84. PubMed ID: 33444661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.